Savant Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$359K Sell
3,971
-124
-3% -$11.4K ﹤0.01% 1084
2025
Q4
$368K Sell
4,095
-193
-5% -$18.3K ﹤0.01% 958
2025
Q3
$422K Buy
4,288
+247
+6% +$24.5K ﹤0.01% 865
2025
Q2
$369K Buy
4,041
+59
+1% +$5.71K ﹤0.01% 872
2025
Q1
$451K Buy
3,982
+205
+5% +$21.9K ﹤0.01% 700
2024
Q4
$399K Sell
3,777
-910
-19% -$97.6K ﹤0.01% 975
2024
Q3
$506K Buy
+4,687
New +$512K ﹤0.01% 864
2024
Q2
Sell
-6,785
Closed -$895K 1350
2024
Q1
$895K Buy
6,785
+4,804
+243% +$600K 0.01% 575
2023
Q4
$241K Sell
1,981
-248
-11% -$27.7K ﹤0.01% 762
2023
Q3
$250K Sell
2,229
-170
-7% -$21.6K ﹤0.01% 706
2023
Q2
$349K Buy
2,399
+65
+3% +$8.83K 0.01% 606
2023
Q1
$302K Buy
2,334
+214
+10% +$26.9K 0.01% 591
2022
Q4
$270K Sell
2,120
-107
-5% -$12.4K 0.01% 491
2022
Q3
$233K Buy
2,227
+24
+1% +$2.63K 0.01% 479
2022
Q2
$231K Buy
2,203
+11
+0.5% +$1.3K 0.01% 493
2022
Q1
$280K Buy
2,192
+427
+24% +$51.5K 0.01% 469
2021
Q4
$218K Sell
1,765
-2
-0.1% -$262 0.01% 527
2021
Q3
$251K Buy
1,767
+107
+6% +$15.7K 0.01% 455
2021
Q2
$259K Buy
1,660
+44
+3% +$7.13K 0.01% 425
2021
Q1
$251K Sell
1,616
-50
-3% -$7.75K 0.01% 401
2020
Q4
$249K Sell
1,666
-82
-5% -$11.6K 0.01% 386
2020
Q3
$231K Sell
1,748
-106
-6% -$13.8K 0.02% 358
2020
Q2
$215K Sell
1,854
-561
-23% -$64.6K 0.02% 369
2020
Q1
$237K Buy
2,415
+1,005
+71% +$132K 0.02% 334
2019
Q4
$205K Buy
+1,410
New +$195K 0.03% 337
2015
Q4
Sell
-2,338
Closed -$213K 228
2015
Q3
$213K Buy
+2,338
New +$234K 0.08% 193

Other funds holding ZBH

Savant Capital's ZBH Position: Q1 2026 in Review

Savant Capital reduced its Zimmer Biomet (ZBH) stake by 3% in Q1 2026, selling an estimated $11.4K and leaving 3,971 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #1084.

Savant Capital first reported a position in ZBH in Q3 2015 and has held it in 26 quarters since. The position peaked at $895K in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Savant Capital held 3,971 shares of Zimmer Biomet worth $359K as of Q1 2026.
  • Savant Capital sold 124 Zimmer Biomet shares in Q1 2026, an estimated $11.4K.
  • Zimmer Biomet made up ﹤0.01% of Savant Capital's portfolio in Q1 2026, its #1084 holding.
  • Savant Capital first reported a position in Zimmer Biomet in Q3 2015 and has held it in 26 quarters since.
  • Savant Capital's Zimmer Biomet position peaked at $895K in Q1 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.